We are very pleased to announce that Helena Koa has joined PDCI as Manager, Market Access, effective today, April 1, 2019! Helena brings a wealth of knowledge and multi-disciplinary insights to PDCI: new product development, pricing and reimbursement, clinical research, health economics, and budget impact analyses. Helena’s experience spans over 15 years in the pharmaceutical industry (Ascensia Diabetes Care, Bristol-Myers Squibb, Sanofi-Aventis, Pfizer) and in consulting, working in a variety of therapeutic areas including oncology, inflammation and neurology.
Helena’s addition to the team reflects PDCI’s continuous growth and success, as well as the growing demand from clients for collaboration with PDCI to navigate the increasingly complex Canadian market access landscape.
Helena holds a Graduate Certificate in Healthcare Management and an M.Sc. in Biochemistry from McGill University along with an MBA from Concordia University.
Helena will be working out of the Ottawa office and can be reached at firstname.lastname@example.org or +1 (613) 742-8225 ext. 29.